Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Karlheinz Doser"'
Publikováno v:
Arzneimittelforschung. 50:328-332
Two different oral tetrazepam (CAS 10379-14-3) formulations (Tetrazepam-ratiopharm film-coated tablets as test preparation and tablets of a reference preparation marketed in France) were investigated in 20 healthy volunteers in order to prove bioequi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6bb839bd17b563f563398e15d66a14f
https://doi.org/10.1055/s-0031-1300210
https://doi.org/10.1055/s-0031-1300210
Autor:
Karlheinz Doser, Peter Arnold, Markus Gaupp, Dieter Schaarschmidt, Ursula Geister, Jürgen Renner
Publikováno v:
Arzneimittelforschung. 51:189-196
Two different oral doxepin (CAS 1668-195) formulations (Doxepin-ratiopharm 25 mg film-coated tablets as test preparation and 25 mg dragées of the reference preparation) were investigated in 30 healthy male and female volunteers in order to prove bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2692e30996dead9c68b140b0292156c6
https://doi.org/10.1055/s-0031-1300024
https://doi.org/10.1055/s-0031-1300024
Publikováno v:
Arzneimittelforschung. 61:247-251
Prasugrel (CAS 150322-43-3), an inhibitor of platelet activation and aggregation, is indicated to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome. If a proton pump inhibitor is co-administered with prasugr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55295927142f906fcb2e2550db27da0a
https://doi.org/10.1055/s-0031-1296195
https://doi.org/10.1055/s-0031-1296195
Publikováno v:
Arzneimittel-Forschung. 50(3)
Two different oral methylprednisolone (CAS 83-43-2) formulations (Methylprednisolon-ratiopharm 8 mg tables as test preparation (T) and tablets of a reference preparation (R)) were investigated in 16 healthy volunteers in order to prove bioequivalence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e22955a1f068847d23310f80560b8db
https://pubmed.ncbi.nlm.nih.gov/10758783
https://pubmed.ncbi.nlm.nih.gov/10758783
Publikováno v:
Arzneimittel-Forschung. 49(7)
An oral solution available as ethanol-free droplets of the fixed drug combination tilidine-HCl 50 mg/naloxone-HCl 4 mg (CAS 27107-79-5 and CAS 465-65-6, respectively; Tilidin-ratiopharm plus Tropfen) was investigated in 12 healthy volunteers together
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8df6a08cc677326f0eee01026f9cd86
https://pubmed.ncbi.nlm.nih.gov/10442208
https://pubmed.ncbi.nlm.nih.gov/10442208